{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T15:07:01Z","timestamp":1773155221738,"version":"3.50.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100012476","name":"Fundamental Research Funds for the Central Universities of Central South University","doi-asserted-by":"crossref","award":["2024ZZTS0176"],"award-info":[{"award-number":["2024ZZTS0176"]}],"id":[{"id":"10.13039\/501100012476","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100012166","name":"National Key R&D Program of China","doi-asserted-by":"crossref","award":["2023YFC2507000"],"award-info":[{"award-number":["2023YFC2507000"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82303571"],"award-info":[{"award-number":["82303571"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-025-14855-w","type":"journal-article","created":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T01:21:08Z","timestamp":1756689668000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Mechanisms for fibrate lipid-lowering drugs in enhancing bladder cancer immunotherapy by inhibiting CD276 expression"],"prefix":"10.1186","volume":"25","author":[{"given":"Cheng","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiahao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Long","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,9,1]]},"reference":[{"issue":"2","key":"14855_CR1","doi-asserted-by":"publisher","first-page":"115","DOI":"10.3322\/caac.21338","volume":"66","author":"W Chen","year":"2016","unstructured":"Chen W, Zheng R, Baade PD, Zhang S, Zeng H, Bray F, Jemal A, Yu XQ, He J. Cancer statistics in china, 2015. Cancer J Clin. 2016;66(2):115\u201332.","journal-title":"Cancer J Clin"},{"issue":"5","key":"14855_CR2","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1097\/JU.0000000000000025","volume":"201","author":"H Ebrahimi","year":"2019","unstructured":"Ebrahimi H, Amini E, Pishgar F, Moghaddam SS, Nabavizadeh B, Rostamabadi Y, Aminorroaya A, Fitzmaurice C, Farzadfar F, Nowroozi MR, et al. Global, regional and National burden of bladder cancer, 1990 to 2016: results from the GBD study 2016. J Urol. 2019;201(5):893\u2013901.","journal-title":"J Urol"},{"issue":"5","key":"14855_CR3","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1007\/s00345-020-03498-0","volume":"39","author":"M Rouanne","year":"2021","unstructured":"Rouanne M, Radulescu C, Adam J, Allory Y. PD-L1 testing in urothelial bladder cancer: essentials of clinical practice. World J Urol. 2021;39(5):1345\u201355.","journal-title":"World J Urol"},{"issue":"1","key":"14855_CR4","doi-asserted-by":"publisher","first-page":"7077","DOI":"10.1038\/s41467-024-51096-0","volume":"15","author":"C Zhang","year":"2024","unstructured":"Zhang C, Li K, Zhu H, Cheng M, Chen S, Ling R, Wang C, Chen D. ITGB6 modulates resistance to anti-CD276 therapy in head and neck cancer by promoting PF4(+) macrophage infiltration. Nat Commun. 2024;15(1):7077.","journal-title":"Nat Commun"},{"issue":"1","key":"14855_CR5","doi-asserted-by":"publisher","first-page":"6222","DOI":"10.1038\/s41467-024-50251-x","volume":"15","author":"M Tian","year":"2024","unstructured":"Tian M, Wei JS, Cheuk AT, Milewski D, Zhang Z, Kim YY, Chou HC, Liu C, Badr S, Pope EG, et al. CAR T-cells targeting FGFR4 and CD276 simultaneously show potent antitumor effect against childhood rhabdomyosarcoma. Nat Commun. 2024;15(1):6222.","journal-title":"Nat Commun"},{"issue":"1","key":"14855_CR6","doi-asserted-by":"publisher","first-page":"5184","DOI":"10.1038\/s41467-022-32849-1","volume":"13","author":"J Adamik","year":"2022","unstructured":"Adamik J, Munson PV, Hartmann FJ, Combes AJ, Pierre P, Krummel MF, Bendall SC, Arguello RJ, Butterfield LH. Distinct metabolic States guide maturation of inflammatory and tolerogenic dendritic cells. Nat Commun. 2022;13(1):5184.","journal-title":"Nat Commun"},{"issue":"5","key":"14855_CR7","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1158\/1078-0432.CCR-20-2584","volume":"27","author":"F Kontos","year":"2021","unstructured":"Kontos F, Michelakos T, Kurokawa T, Sadagopan A, Schwab JH, Ferrone CR, Ferrone S. B7-H3: an attractive target for antibody-based immunotherapy. Clin Cancer Research: Official J Am Association Cancer Res. 2021;27(5):1227\u201335.","journal-title":"Clin Cancer Research: Official J Am Association Cancer Res"},{"key":"14855_CR8","doi-asserted-by":"publisher","first-page":"1445526","DOI":"10.3389\/fonc.2024.1445526","volume":"14","author":"Q Zhou","year":"2024","unstructured":"Zhou Q, Xu J, Chen X, Ouyang J, Mao C, Zhang Z. CD276 as a promising diagnostic and prognostic biomarker for bladder cancer through bioinformatics and clinical research. Front Oncol. 2024;14:1445526.","journal-title":"Front Oncol"},{"issue":"8","key":"14855_CR9","doi-asserted-by":"publisher","first-page":"2363","DOI":"10.1016\/j.drudis.2022.05.007","volume":"27","author":"A Mahmoudi","year":"2022","unstructured":"Mahmoudi A, Jamialahmadi T, Johnston TP, Sahebkar A. Impact of Fenofibrate on NAFLD\/NASH: A genetic perspective. Drug Discovery Today. 2022;27(8):2363\u201372.","journal-title":"Drug Discovery Today"},{"issue":"3","key":"14855_CR10","first-page":"376","volume":"23","author":"L Jin","year":"2023","unstructured":"Jin L, Hua H, Ji Y, Jia Z, Peng M, Huang S. Anti-inflammatory role of Fenofibrate in treating diseases. Biomolecules Biomed. 2023;23(3):376\u201391.","journal-title":"Biomolecules Biomed"},{"issue":"17","key":"14855_CR11","doi-asserted-by":"publisher","first-page":"4431","DOI":"10.1158\/0008-5472.CAN-21-0052","volume":"81","author":"A Chekaoui","year":"2021","unstructured":"Chekaoui A, Ertl HCJ. PPAR\u03b1 agonist Fenofibrate enhances cancer vaccine efficacy. Cancer Res. 2021;81(17):4431\u201340.","journal-title":"Cancer Res"},{"issue":"1","key":"14855_CR12","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1124\/jpet.104.068312","volume":"311","author":"B Brunmair","year":"2004","unstructured":"Brunmair B, Lest A, Staniek K, Gras F, Scharf N, Roden M, Nohl H, Waldhausl W, Furnsinn C. Fenofibrate impairs rat mitochondrial function by Inhibition of respiratory complex I. J Pharmacol Exp Ther. 2004;311(1):109\u201314.","journal-title":"J Pharmacol Exp Ther"},{"key":"14855_CR13","doi-asserted-by":"publisher","first-page":"113730","DOI":"10.1016\/j.ejmech.2021.113730","volume":"223","author":"X Qiao","year":"2021","unstructured":"Qiao X, Gao YY, Zheng LX, Ding XJ, Xu LW, Hu JJ, Gao WZ, Xu JY. Targeting ROS-AMPK pathway by multiaction Platinum(IV) prodrugs containing hypolipidemic drug Bezafibrate. Eur J Med Chem. 2021;223:113730.","journal-title":"Eur J Med Chem"},{"issue":"1","key":"14855_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s43440-023-00553-6","volume":"76","author":"A Alizadehasl","year":"2024","unstructured":"Alizadehasl A, Alavi MS, Boudagh S, Alavi MS, Mohebi S, Aliabadi L, Akbarian M, Ahmadi P, Mannarino MR, Sahebkar A. Lipid-lowering drugs and cancer: an updated perspective. Pharmacol Rep. 2024;76(1):1\u201324.","journal-title":"Pharmacol Rep"},{"issue":"20","key":"14855_CR15","doi-asserted-by":"publisher","first-page":"e2300286","DOI":"10.1002\/advs.202300286","volume":"10","author":"Y Wang","year":"2023","unstructured":"Wang Y, Wang W, Gu R, Chen J, Chen Q, Lin T, Wu J, Hu Y, Yuan A. In situ vaccination with Mitochondria-Targeting Immunogenic death inducer elicits CD8(+) T Cell-Dependent antitumor immunity to boost tumor immunotherapy. Adv Sci (Weinh). 2023;10(20):e2300286.","journal-title":"Adv Sci (Weinh)"},{"issue":"1","key":"14855_CR16","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s12943-023-01751-9","volume":"22","author":"AA Getu","year":"2023","unstructured":"Getu AA, Tigabu A, Zhou M, Lu J, Fodstad \u00d8, Tan M. New frontiers in immune checkpoint B7-H3 (CD276) research and drug development. Mol Cancer. 2023;22(1):43.","journal-title":"Mol Cancer"},{"issue":"1","key":"14855_CR17","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.ygyno.2021.04.013","volume":"162","author":"M Deng","year":"2021","unstructured":"Deng M, Wu D, Zhang Y, Jin Z, Miao J. MiR-29c downregulates tumor-expressed B7-H3 to mediate the antitumor NK-cell functions in ovarian cancer. Gynecol Oncol. 2021;162(1):190\u20139.","journal-title":"Gynecol Oncol"},{"issue":"1","key":"14855_CR18","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1186\/s12967-024-05689-4","volume":"22","author":"I Hagelstein","year":"2024","unstructured":"Hagelstein I, Wessling L, Rochwarger A, Zekri L, Klimovich B, Tegeler CM, Jung G, Sch\u00fcrch CM, Salih HR, Lutz MS. Targeting CD276 for T cell-based immunotherapy of breast cancer. J Translational Med. 2024;22(1):902.","journal-title":"J Translational Med"},{"issue":"1","key":"14855_CR19","doi-asserted-by":"publisher","first-page":"2419686","DOI":"10.1080\/2162402X.2024.2419686","volume":"13","author":"M Emaldi","year":"2024","unstructured":"Emaldi M, Rey-Iborra E, Mar\u00edn \u00c1, Mosteiro L, Lecumberri D, \u00d8yjord T, Roncier N, M\u00e6landsmo GM, Angulo JC, Errarte P, et al. Impact of B7-H3 expression on metastasis, immune exhaustion and JAK\/STAT and PI3K\/AKT pathways in clear cell renal cell carcinoma. Oncoimmunology. 2024;13(1):2419686.","journal-title":"Oncoimmunology"},{"key":"14855_CR20","doi-asserted-by":"crossref","unstructured":"Cizkova K, Tauber Z. Fibrates affect levels of phosphorylated p38 in intestinal cells in a Differentiation-Dependent manner. Int J Mol Sci. 2023;24(9):7695.","DOI":"10.3390\/ijms24097695"},{"issue":"8","key":"14855_CR21","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.ejcb.2011.02.005","volume":"90","author":"D Yamasaki","year":"2011","unstructured":"Yamasaki D, Kawabe N, Nakamura H, Tachibana K, Ishimoto K, Tanaka T, Aburatani H, Sakai J, Hamakubo T, Kodama T, et al. Fenofibrate suppresses growth of the human hepatocellular carcinoma cell via PPAR\u03b1-independent mechanisms. Eur J Cell Biol. 2011;90(8):657\u201364.","journal-title":"Eur J Cell Biol"},{"key":"14855_CR22","doi-asserted-by":"crossref","unstructured":"Tsogas FK, Majerczyk D, Hart PC. Possible role of Metformin as an immune modulator in the tumor microenvironment of ovarian cancer. Int J Mol Sci. 2021;22(2):867.","DOI":"10.3390\/ijms22020867"},{"issue":"15","key":"14855_CR23","doi-asserted-by":"publisher","first-page":"e2304328","DOI":"10.1002\/adma.202304328","volume":"36","author":"L Yi","year":"2024","unstructured":"Yi L, Jiang X, Zhou Z, Xiong W, Xue F, Liu Y, Xu H, Fan B, Li Y, Shen J. A hybrid nanoadjuvant simultaneously depresses PD-L1\/TGF-\u03b21 and activates cGAS-STING pathway to overcome Radio-Immunotherapy resistance. Adv Mater (Deerfield Beach Fla). 2024;36(15):e2304328.","journal-title":"Adv Mater (Deerfield Beach Fla)"},{"issue":"1","key":"14855_CR24","doi-asserted-by":"publisher","first-page":"53","DOI":"10.36401\/JIPO-23-18","volume":"7","author":"K Feustel","year":"2024","unstructured":"Feustel K, Martin J, Falchook GS. B7-H3 inhibitors in oncology clinical trials: A review. J Immunotherapy Precision Oncol. 2024;7(1):53\u201366.","journal-title":"J Immunotherapy Precision Oncol"},{"key":"14855_CR25","doi-asserted-by":"crossref","unstructured":"Aggarwal C, Prawira A, Antonia S, Rahma O, Tolcher A, Cohen RB, Lou Y, Hauke R, Vogelzang N. D PZ : Dual checkpoint targeting of B7-H3 and PD-1 with enoblituzumab and pembrolizumab in advanced solid tumors: interim results from a multicenter phase I\/II trial. J Immunother Cancer. 2022;10(4):e004424.","DOI":"10.1136\/jitc-2021-004424"},{"key":"14855_CR26","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.jneuroim.2017.07.002","volume":"310","author":"X Chen","year":"2017","unstructured":"Chen X, Meng X, Foley NM, Shi X, Liu M, Chai Y, Li Y, Redmond HP, Wang J, Wang JH. Activation of the TLR2-mediated downstream signaling pathways NF-\u03baB and MAPK is responsible for B7-H3-augmented inflammatory response during S. pneumoniae infection. J Neuroimmunol. 2017;310:82\u201390.","journal-title":"J Neuroimmunol"},{"issue":"1","key":"14855_CR27","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1186\/s12885-024-12402-7","volume":"24","author":"ZY Zhang","year":"2024","unstructured":"Zhang ZY, Xu JH, Zhang JL, Lin YX, Ou-Yang J. CD276 enhances Sunitinib resistance in clear cell renal cell carcinoma by promoting DNA damage repair and activation of FAK-MAPK signaling pathway. BMC Cancer. 2024;24(1):650.","journal-title":"BMC Cancer"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-14855-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-025-14855-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-14855-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T00:21:52Z","timestamp":1757463712000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-025-14855-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,1]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["14855"],"URL":"https:\/\/doi.org\/10.1186\/s12885-025-14855-w","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,1]]},"assertion":[{"value":"17 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval for mice experiments was approved by the Institutional Animal Care and Use Committee of Wenzhou Institute, University of Chinese Academy of Sciences (WIUCAS24080604). All experiments were performed in accordance with relevant guidelines and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1404"}}